Veritas Genetics Sets Up China R&D Center in Hangzhou

Veritas Genetics, a Boston genetic testing startup, has established a China R&D center in the Hangzhou Economic & Technological Development Area. The center will be dedicated to developing products that address the unique genetic needs of Asian populations. Veritas intends to make accessible screening and testing products that are available globally. In May, Lilly Ventures Asia backed Veritas' initial $10 million funding. So far, Veritas has an oral BRCA1-BRCA2 breast and ovarian cancer test available in the US and Europe. More details.... Share this with colleagues: // //